Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers

Ceftizoxime (C<sub>13</sub>H<sub>12</sub>N<sub>5</sub>NaO<sub>5</sub>S<sub>2</sub>)is a parenteral, third-generationcephalosporin antibiotic used to treat bacterial infections including ear, nose, and throat infections. In this work, pectin...

Full description

Bibliographic Details
Main Authors: Pawan Kumar, Vinod Kumar, Ravinder Kumar, Catalin Iulian Pruncu
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/10/8/1452
id doaj-e5fc631a0b81420e8d856fc2b7dcccb8
record_format Article
spelling doaj-e5fc631a0b81420e8d856fc2b7dcccb82020-11-25T03:25:53ZengMDPI AGNanomaterials2079-49912020-07-01101452145210.3390/nano10081452Fabrication and Characterization of Ceftizoxime-Loaded Pectin NanocarriersPawan Kumar0Vinod Kumar1Ravinder Kumar2Catalin Iulian Pruncu3Department of Materials Science and Nanotechnology, Deenbandhu Chhotu Ram University of Science and Technology, Murthal 131039, IndiaDepartment of Bio and Nano Technology, Guru Jambheshwar University of Science and Technology, Hisar 125001, IndiaDepartment of Mechanical Engineering, Lovely Professional University, Phagwara 144411, IndiaMechanical Engineering Department, University of Birmingham, Birmingham B15 2TT, UKCeftizoxime (C<sub>13</sub>H<sub>12</sub>N<sub>5</sub>NaO<sub>5</sub>S<sub>2</sub>)is a parenteral, third-generationcephalosporin antibiotic used to treat bacterial infections including ear, nose, and throat infections. In this work, pectin has been used as a nanocarrier for ceftizoxime due to its high biocompatibility and non-toxicity with tunable surface properties. Ceftizoxime-loaded pectin nanocarriers (CPN) were successfully synthesized by the solvent displacement method. Optimization of nanoformulation was done by response surface methodology using Design-Expert software. The optimized formulation examined various in-vitro characterizations such as particle size, morphology, and FTIR studies. TEM results revealed irregular shape nanoparticles within the range of 29–110 nm. The in-vitro drug release using the dialysis method was performed after 24h where nanoformulation showed sustained drug release. Drug-loaded nanoparticles revealed good antimicrobial activity against <i>Bacillus cereus, Bacilluspolymyxa, Enterobacteraerogenes</i>, and<i>Pseudomonasaeruginosa</i>.https://www.mdpi.com/2079-4991/10/8/1452Ceftizoximepectinsolvent displacementnanocarriersantibacterial activity
collection DOAJ
language English
format Article
sources DOAJ
author Pawan Kumar
Vinod Kumar
Ravinder Kumar
Catalin Iulian Pruncu
spellingShingle Pawan Kumar
Vinod Kumar
Ravinder Kumar
Catalin Iulian Pruncu
Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers
Nanomaterials
Ceftizoxime
pectin
solvent displacement
nanocarriers
antibacterial activity
author_facet Pawan Kumar
Vinod Kumar
Ravinder Kumar
Catalin Iulian Pruncu
author_sort Pawan Kumar
title Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers
title_short Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers
title_full Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers
title_fullStr Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers
title_full_unstemmed Fabrication and Characterization of Ceftizoxime-Loaded Pectin Nanocarriers
title_sort fabrication and characterization of ceftizoxime-loaded pectin nanocarriers
publisher MDPI AG
series Nanomaterials
issn 2079-4991
publishDate 2020-07-01
description Ceftizoxime (C<sub>13</sub>H<sub>12</sub>N<sub>5</sub>NaO<sub>5</sub>S<sub>2</sub>)is a parenteral, third-generationcephalosporin antibiotic used to treat bacterial infections including ear, nose, and throat infections. In this work, pectin has been used as a nanocarrier for ceftizoxime due to its high biocompatibility and non-toxicity with tunable surface properties. Ceftizoxime-loaded pectin nanocarriers (CPN) were successfully synthesized by the solvent displacement method. Optimization of nanoformulation was done by response surface methodology using Design-Expert software. The optimized formulation examined various in-vitro characterizations such as particle size, morphology, and FTIR studies. TEM results revealed irregular shape nanoparticles within the range of 29–110 nm. The in-vitro drug release using the dialysis method was performed after 24h where nanoformulation showed sustained drug release. Drug-loaded nanoparticles revealed good antimicrobial activity against <i>Bacillus cereus, Bacilluspolymyxa, Enterobacteraerogenes</i>, and<i>Pseudomonasaeruginosa</i>.
topic Ceftizoxime
pectin
solvent displacement
nanocarriers
antibacterial activity
url https://www.mdpi.com/2079-4991/10/8/1452
work_keys_str_mv AT pawankumar fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers
AT vinodkumar fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers
AT ravinderkumar fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers
AT cataliniulianpruncu fabricationandcharacterizationofceftizoximeloadedpectinnanocarriers
_version_ 1724595033439469568